01 / Context
The broad price gap is real, but averages are not quotes
HHS ASPE’s 2024 summary of RAND analyses reports that, using 2022 data, U.S. prices across brand and generic drugs were nearly 2.78 times prices in comparison countries. It also reports that U.S. brand-drug prices were at least 3.22 times comparison-country prices after estimated U.S. rebate adjustments.
Those figures describe a market-level pattern. They do not mean that every medication, strength, or package is cheaper in every European country. Generic pricing can behave differently, launch timing varies, confidential rebates are usually unavailable, and a U.S. cash price is not the same thing as a plan’s net cost.
02 / Definitions
Know which price you are comparing
| Price label | What it can mean | Comparison caution |
|---|---|---|
| U.S. cash price | A quoted retail amount for a patient paying without insurance | Varies by pharmacy, discount program, location, and date. |
| Wholesale acquisition cost | A manufacturer list-price benchmark | Does not include all rebates, discounts, or dispensing economics. |
| Plan net cost | Cost after contract terms, rebates, and other adjustments | Often confidential and plan-specific. |
| European public price | A published national or pharmacy reference | Taxes, reimbursement, dispensing fees, and private discounts may differ. |
| Ex-works or supplier reference | A price before downstream services and logistics | Should not be compared directly with a fully loaded U.S. patient price. |
03 / Calculation
A defensible comparison workflow
- Match identity.Confirm active ingredient, brand or product, manufacturer, dosage form, strength, and market.
- Match quantity.Convert each package to comparable tablets, capsules, vials, milliliters, or treatment units.
- Record price type.Label each figure as cash, list, public, ex-works, or another defined benchmark.
- Normalize currency.Use a stated exchange rate and conversion date; do not silently mix currencies.
- Add known costs.Separate dispensing, handling, shipping, temperature control, taxes, and route-specific review.
- Publish limitations.Show the source date, missing variables, and why the result is a reference rather than a guaranteed quote.
04 / Example
Why unit-level math can still mislead
Suppose one market lists 28 tablets and another source quotes 30 tablets. Dividing each price by tablet produces a useful normalization, but it is not the end of the analysis. The products may have different labeling, approved indications, pack configurations, manufacturer channels, or dispensing requirements. A unit price is a decision aid, not proof that products are interchangeable.
05 / Research
Use catalog pages as a starting dataset
The US Med Access catalog publishes dated EU package references beside captured U.S. cash-price context. Every product page identifies the package count, range, source scope, and last review date. The pages are designed to answer “is this case worth investigating?” rather than “what will the final transaction cost?”
Before relying on a number, read the full pricing methodology and request a current package review. Availability, exchange rates, U.S. benchmark pricing, and route-specific costs can change.
Frequently asked questions
Clear answers for the next decision.
01Are prescription drugs always cheaper in Europe than in the United States?
No. Aggregate studies show large differences, especially for brand drugs, but results vary by product, package, country, price basis, and date.
02Is a U.S. cash price the same as the price a health plan pays?
No. Cash price, wholesale acquisition cost, negotiated plan cost, and patient out-of-pocket cost are different measures.
03Should medication prices be compared per tablet or per package?
Both views can be useful. Unit normalization helps compare different package quantities, but the original package, dosage form, manufacturer, and route must remain visible.
04How often should a medication comparison be refreshed?
Refresh it before any decision and whenever the source price, currency, package, availability, or intended route changes.
Primary and authoritative sources
Sources used for this guide
- HHS ASPE: Comparing Prescription Drugs in the U.S. and Other Countries
- HHS ASPE: International Prescription Drug Price Comparisons
- US Med Access Pricing Methodology
- Drugs.com Price Guide
This page is general information, not medical or legal advice. Requirements and source pages can change; verify the current rule for the specific product and route.